Zhejiang Hua Fang Pharmaceutical Co., Ltd., Zhejiang Huangyan Sifang chemical factory, create in September 1993, joint-stock cooperative enterprises, headquarters is located in Zhejiang Huangyan Economic Development Zone, Jiangkou light investment zone, covering an area of 46666.9m2, the construction area of feasibility m2, the total assets of 300 million yuan, fixed assets of 1.5 billion yuan. In 2005 in Weifang, Shandong invested 1.6 million to set up a Quartet branch in Shandong. Company existing staff 500 people, including more than 180 technical personnel.Company is a high-tech enterprises in Zhejiang Province, with provincial high and new technology research and development center, Huangyan District first academician workstation, and the State Food and drug supervision and Management Bureau of Sichuan antibiotic research, Lanzhou University, Shenyang Pharmaceutical University, East China University of science and University, Fudan University, Zhejiang University, Zhejiang University of technology colleges and universities to establish a long-term relations of cooperation. Companies included in the national technological innovation fund projects 1, national torch project 3, 1 national key new products, 9 provincial-level high-tech products, municipal high-tech product 6, 7 invention patents, continuous 10 years was awarded Taizhou Huangyan hundred enterprises. Company obtained Zhejiang Province food and Drug Administration issued a pharmaceutical production license on November 9, 2009, the production scope of cefprozil, cephalosporin hydrochloride card pivoxil, cefotaxime Tuo Lun pivoxil, ceftibuten APIs. November 25, 2011 was issued by the Japanese Ministry of health "foreign drug manufacturing certificate". 2012 December 31, get state food and Drug Administration issued cefprozil raw material drug registration approval. In March 2014 achieved cefprozil raw material medicine a new version of the GMP certificate.The company has perfect safety, environmental protection, occupational health management body, in 2008 through the ISO9001, ISO14001, ISO18001 certification, the company has a daily processing capacity of 1000 tons of sewage treatment station, daily processing capacity of 36 million cubic meters of gas processing station, the control of the "three wastes" reach national emission standard.Companies according to the new version of the GMP specification requirements to establish and run the quality management system, to ensure that the company's production of product quality is uniform, stable, quality. At present, it has formed the anti infective drugs, anti allergy drugs, cardiovascular drugs, antipyretic and analgesic drugs and all kinds of intermediates of many professional production line, annual production capacity reached 1500 tons. In 2013 the company sales revenue of 2.3 billion, products are exported to in Europe, the United States, India, Japan, South Korea and other foreign markets, and well-known enterprises at home and abroad such as Teva pharmaceuticals, Bristol Myers Squibb pharmaceutical in the United States, Japan Meiji pharmaceutical, Otsuka, Glaxo, Sinopharm group, medicine group, Tasly group, Shandong Luoxin, Shanxi Pude, Hainan Haiyao, Yongning pharmaceutical supporting. The quality of the products by users.The Chinese people always uphold the purpose of quality Seiko products, to serve the human health.
CN
